Amended Appendix 4C - quarterly
Filed with ASX · · 7 pages · English
Clinuvel Pharmaceuticals Limited on 6ix
Story so far
Earlier from Clinuvel Pharmaceuticals
- NICE England Update on SCENESSE
- CLINUVEL reaches agreement on German SCENESSE pricing
- CLINUVEL agrees with FDA on New Drug Application timelines
- SCENESSE - NICE England Update
- FDA Schedules Pre-NDA Meeting for SCENESSE
Later from Clinuvel Pharmaceuticals
- Preliminary Final Report
- CLINUVEL provides update on SCENESSE FDA filing
- Preliminary assessment received from NICE
- CLINUVEL hosts European EPP Expert Meeting
- CLINUVEL to take 100% ownership of VALLAURIX joint venture
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals